MET-targeted therapy (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MET-targeted therapy (investigational), covering 2025-12-05 to 2025-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial) [Phase 2]